Literature DB >> 24627615

Catheter Aspiration after Every Stage during Primary Percutaneous Angioplasty; ADMIT Trial.

Yoav Turgeman1, Limor Ilan Bushari1, Dante Antonelli1, Alexander Feldman1, Malka Yahalom1, Lev Bloch1, Khalid Suleiman1.   

Abstract

We assess the epicardial and microcirculation flow characteristics, and clinical outcome by using catheter aspiration after each stage of primary percutaneous coronary intervention (PPCI). Conflicting data are reported regarding early and late benefit of using aspiration catheter in the initial phase PPCI. A total of 100 patients with ST-segment elevation acute myocardial infarction (STEMI) were included: 51 underwent PPCI without using an aspiration device (SA group) and 49 underwent PPCI by activating an aspiration catheter after each stage of procedure; wiring, ballooning and stenting, respectively (MA group). Thrombolysis in myocardial infarction (TIMI) flow grade, TIMI frame counts and myocardial blush grade (MBG) were evaluated in each group during every stage of procedure. Major adverse cardiac events were evaluated in the index hospitalization and during 30 and 180 days of follow-up. A TIMI flow grade 2-3 was more prevalent in the MA group compared with the SA group only after wiring: 65.9 versus 39.1% (p = 0.01), but TIMI frame counts were lower in the MA versus SA group throughout all procedural steps. MBG 2-3 was statistically higher in the MA group compared with the SA group mainly after wiring. After stenting there were no significant changes in both epicardial and microcirculation flow parameters. There were no significant differences between the groups in early and late clinical outcomes. Improved flow parameters were noticed in the MA group only by activating the aspiration device after wiring. This early advantage disappeared after stenting. The initial better flow characteristic in the MA group was not translated into a better early or late clinical outcome.

Entities:  

Keywords:  TIMI flow; TIMI frame counts; aspiration catheter; myocardial blush grade; primary PCI; stenting

Year:  2014        PMID: 24627615      PMCID: PMC3933502          DOI: 10.1055/s-0033-1358782

Source DB:  PubMed          Journal:  Int J Angiol        ISSN: 1061-1711


  19 in total

1.  Characterization of plaque prolapse after drug-eluting stent implantation in diabetic patients: a three-dimensional volumetric intravascular ultrasound outcome study.

Authors:  Hideki Futamatsu; Manel Sabaté; Dominick J Angiolillo; Pilar Jimenez-Quevedo; Cecilia Corros; Kino Morikawa-Futamatsu; Fernando Alfonso; Julie Jiang; Pavel Cervinka; Rosana Hernandez-Antolin; Carlos Macaya; Theodore A Bass; Marco A Costa
Journal:  J Am Coll Cardiol       Date:  2006-08-28       Impact factor: 24.094

2.  Impact of normalized myocardial perfusion after successful angioplasty in acute myocardial infarction.

Authors:  Gregg W Stone; Michael A Peterson; Alexandra J Lansky; George Dangas; Roxana Mehran; Martin B Leon
Journal:  J Am Coll Cardiol       Date:  2002-02-20       Impact factor: 24.094

3.  Improved outcome with AngioJet thrombectomy during primary stenting in acute myocardial infarction patients with high-grade thrombus.

Authors:  Samin K Sharma; Frank Tamburrino; Angelica M Mares; Annapoorna S Kini
Journal:  J Invasive Cardiol       Date:  2006-07       Impact factor: 2.022

4.  The Thrombolysis in Myocardial Infarction (TIMI) trial. Phase I findings.

Authors: 
Journal:  N Engl J Med       Date:  1985-04-04       Impact factor: 91.245

5.  Clinical value of 12-lead electrocardiogram after successful reperfusion therapy for acute myocardial infarction. Zwolle Myocardial infarction Study Group.

Authors:  A W van 't Hof; A Liem; M J de Boer; F Zijlstra
Journal:  Lancet       Date:  1997-08-30       Impact factor: 79.321

6.  Adjunctive mechanical devices to prevent distal embolization in patients undergoing mechanical revascularization for acute myocardial infarction: a meta-analysis of randomized trials.

Authors:  Giuseppe De Luca; Harry Suryapranata; Gregg W Stone; David Antoniucci; Franz-Joseph Neumann; Massimo Chiariello
Journal:  Am Heart J       Date:  2007-03       Impact factor: 4.749

Review 7.  Coronary intervention in thrombus-rich lesions: beyond stents and glycoprotein IIb/IIIa inhibitors.

Authors:  Amir Halkin; Gad Keren; Gregg W Stone; David R Holmes; Uri Rosenschein
Journal:  Isr Med Assoc J       Date:  2003-11       Impact factor: 0.892

8.  Plaque gruel of atheromatous coronary lesion may contribute to the no-reflow phenomenon in patients with acute coronary syndrome.

Authors:  Jun-ichi Kotani; Shinsuke Nanto; Gary S Mintz; Masafumi Kitakaze; Tomoki Ohara; Takakazu Morozumi; Seiki Nagata; Masatsugu Hori
Journal:  Circulation       Date:  2002-09-24       Impact factor: 29.690

9.  Angiographic assessment of myocardial reperfusion in patients treated with primary angioplasty for acute myocardial infarction: myocardial blush grade. Zwolle Myocardial Infarction Study Group.

Authors:  A W van 't Hof; A Liem; H Suryapranata; J C Hoorntje; M J de Boer; F Zijlstra
Journal:  Circulation       Date:  1998-06-16       Impact factor: 29.690

10.  Guidelines for percutaneous coronary interventions. The Task Force for Percutaneous Coronary Interventions of the European Society of Cardiology.

Authors:  Sigmund Silber; Per Albertsson; Francisco F Avilés; Paolo G Camici; Antonio Colombo; Christian Hamm; Erik Jørgensen; Jean Marco; Jan-Erik Nordrehaug; Witold Ruzyllo; Philip Urban; Gregg W Stone; William Wijns
Journal:  Eur Heart J       Date:  2005-03-15       Impact factor: 29.983

View more
  2 in total

Review 1.  Long-term outcomes with aspiration thrombectomy for patients undergoing primary percutaneous coronary intervention: A meta-analysis of randomized trials.

Authors:  Akram Y Elgendy; Islam Y Elgendy; Ahmed N Mahmoud; Anthony A Bavry
Journal:  Clin Cardiol       Date:  2017-04-13       Impact factor: 2.882

Review 2.  Aspiration thrombectomy prior to percutaneous coronary intervention in ST-elevation myocardial infarction: a systematic review and meta-analysis.

Authors:  Regina El Dib; Frederick Alan Spencer; Erica Aranha Suzumura; Huda Gomaa; Joey Kwong; Gordon Henry Guyatt; Per Olav Vandvik
Journal:  BMC Cardiovasc Disord       Date:  2016-06-02       Impact factor: 2.298

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.